Drugs Made In America Acquisition Corp. (NasdaqGM: DMAA)
Financials · Capital Markets · US
$10.85
-0.37% today · +5.4% 1Y
Drugs Made In America Acquisition Corp. (NasdaqGM: DMAA) operates in the Capital Markets industry within the Financials sector. The company is valued at $263.40M and employs 2 people.
Over the last twelve months the share price has gained 5.4%, trading between 10.26 and 10.89.
Tweenvest scores Drugs Made In America Acquisition Corp. across four factors: quality 18/100, value 52/100. Its strongest factor is value.
DMAA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $263.40M
- Revenue (TTM)
- —
- P/E
- 58.75
- EPS
- 0.18
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $10.89
- 52-week low
- $10.26
- Avg volume (3M)
- —
- Shares outstanding
- 24.28M
- Employees
- 2
- Next earnings
- —
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
- ISIN
- KYG2847J1040
- Founded
- 2024
- Listed since
- Jan 27, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Spirits Capital CorporationOTCPK: SSCC | $265.86M | $— | — |
| The Korea Fund, Inc.NYSE: KF | $265.09M | $63.75 | -7.37% |
| Oaktree Acquisition Corp. III Life SciencesNasdaqGM: OACC | $264.26M | $10.75 | -0.09% |
| EUWAX AktiengesellschaftDB: EUX | $263.53M | €45.70 | +1.33% |
| Kazakhstan Stock Exchange Joint-Stock CompanyKAS: KASE | $263.39M | KZT111,000.00 | -1.76% |
| Neuberger Berman Income Funds - Neuberger Municipal Fund Inc.NYSEAM: NBH | $263.30M | $8.89 | -2.84% |
| Al Ramz Corporation Investment and Development P.J.S.C.DFM: ALRAMZ | $262.00M | AED1.75 | +17.45% |
| NYLI MacKay DefinedTerm Muni Opportunities FundNYSE: MMD | $261.60M | $13.93 | +1.38% |
Figures last refreshed Oct 11, 2026.